{
  "name": "pharma",
  "sector": "pharmaceuticals",
  "version": "1.0.0",
  "description": "MNPI patterns for pharmaceutical sector: clinical trials, FDA actions, patent expirations, M&A",
  "is_system_library": true,
  "patterns": [
    {"pattern": "phase (3|III|three) results", "pattern_type": "regex", "risk_level": "high", "description": "Phase 3 clinical trial results"},
    {"pattern": "FDA approval", "pattern_type": "keyword", "risk_level": "high", "description": "FDA approval decision"},
    {"pattern": "complete response letter", "pattern_type": "keyword", "risk_level": "high", "description": "FDA CRL rejection"},
    {"pattern": "NDA (approved|rejected|filed|submission)", "pattern_type": "regex", "risk_level": "high", "description": "New Drug Application status"},
    {"pattern": "BLA (approved|rejected|filed)", "pattern_type": "regex", "risk_level": "high", "description": "Biologics License Application"},
    {"pattern": "clinical hold", "pattern_type": "keyword", "risk_level": "high", "description": "FDA clinical hold on trial"},
    {"pattern": "accelerated approval", "pattern_type": "keyword", "risk_level": "high", "description": "FDA accelerated approval pathway"},
    {"pattern": "breakthrough therapy designation", "pattern_type": "keyword", "risk_level": "high", "description": "FDA breakthrough designation"},
    {"pattern": "patent expir(y|ation|ed)", "pattern_type": "regex", "risk_level": "medium", "description": "Patent expiration event"},
    {"pattern": "generic entr(y|ance)", "pattern_type": "regex", "risk_level": "medium", "description": "Generic competitor market entry"},
    {"pattern": "PDUFA date", "pattern_type": "keyword", "risk_level": "high", "description": "FDA prescription drug user fee act action date"},
    {"pattern": "advisory committee (vote|recommendation|meeting)", "pattern_type": "regex", "risk_level": "high", "description": "FDA advisory committee outcome"},
    {"pattern": "data safety monitoring board", "pattern_type": "keyword", "risk_level": "high", "description": "DSMB interim review"},
    {"pattern": "interim (analysis|data|readout)", "pattern_type": "regex", "risk_level": "high", "description": "Clinical trial interim data release"},
    {"pattern": "primary endpoint (met|missed|achieved)", "pattern_type": "regex", "risk_level": "high", "description": "Clinical trial primary endpoint outcome"},
    {"pattern": "statistically significant", "pattern_type": "keyword", "risk_level": "medium", "description": "Statistical significance claim for trial data"},
    {"pattern": "p(-| )?value (of |< |=|below) 0\\.0[0-9]", "pattern_type": "regex", "risk_level": "medium", "description": "P-value results from clinical data"},
    {"pattern": "license agreement", "pattern_type": "keyword", "risk_level": "medium", "description": "Licensing deal discussion"},
    {"pattern": "milestone payment", "pattern_type": "keyword", "risk_level": "medium", "description": "Milestone payment trigger"},
    {"pattern": "out-licensing", "pattern_type": "keyword", "risk_level": "medium", "description": "Out-licensing activity"},
    {"pattern": "acquisition target", "pattern_type": "keyword", "risk_level": "high", "description": "M&A target identification"},
    {"pattern": "due diligence", "pattern_type": "keyword", "risk_level": "high", "description": "M&A due diligence process"},
    {"pattern": "merger (discussions?|negotiations?|talks?)", "pattern_type": "regex", "risk_level": "high", "description": "Merger discussion"},
    {"pattern": "manufacturing defect", "pattern_type": "keyword", "risk_level": "medium", "description": "Production quality issue"},
    {"pattern": "product recall", "pattern_type": "keyword", "risk_level": "high", "description": "Product recall event"},
    {"pattern": "warning letter", "pattern_type": "keyword", "risk_level": "high", "description": "FDA warning letter received"},
    {"pattern": "consent decree", "pattern_type": "keyword", "risk_level": "high", "description": "FDA consent decree"},
    {"pattern": "safety signal", "pattern_type": "keyword", "risk_level": "high", "description": "Adverse safety signal detected"},
    {"pattern": "black box warning", "pattern_type": "keyword", "risk_level": "high", "description": "FDA black box warning addition"},
    {"pattern": "market withdrawal", "pattern_type": "keyword", "risk_level": "high", "description": "Voluntary or involuntary market withdrawal"}
  ]
}
